19 Sep 2025
💉FDA Notice on Vaccines and Biological Products Advisory Committee Meeting
Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Southern Hemisphere Influenza Virus Vaccines; Center for Biologics Evaluation and Research (CBER) Allergen Standardization Program
Summary
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$ - Med
This notice establishes a public meeting regarding influenza virus vaccines and allergen standardization, where businesses can provide comments and insights that may influence regulatory decisions. Such input is critical for stakeholders in the health and pharmaceuticals sectors, reflecting compliance and market dynamics.